Pujante Pedro, Hellín María D, Fornovi Aisa, Martínez Camblor Pablo, Ferrer Mercedes, García-Zafra Victoria, Hernández Antonio M, Frutos María D, Luján-Monpeán Juan, Tébar Javier
Servicio de Endocrinología y Nutrición, Hospital Vital Álvarez Buylla, Mieres, Asturias, Spain.
Servicio de Endocrinología y Nutrición, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain.
Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):812-8. doi: 10.1016/j.rec.2013.05.018. Epub 2013 Aug 2.
Bariatric surgery is a valuable tool for metabolic control in obese diabetic patients. The aim of this study was to determine changes in weight and carbohydrate and lipid metabolism in obese diabetic patients during the first 4 years after bariatric surgery.
A retrospective study was performed in 104 patients (71 women; mean age, 53.0 [0.9] years; mean body mass index, 46.8 [0.7]) with type 2 diabetes mellitus (median duration, 3 years) who underwent laparoscopic proximal gastric bypass.
Blood glucose levels and glycated hemoglobin concentrations decreased during the first 1-3 postoperative months. Values stabilized for the rest of the study period, allowing hypoglycemic treatment to be discontinued in 80% of the patients. No significant differences were observed as a function of the body mass index, diabetes mellitus duration, or previous antidiabetic treatment. Weight decreased during the first 15-24 months and slightly increased afterward. Levels of total cholesterol, triglycerides, and low-density lipoprotein significantly decreased, and target values were reached after 12 months in 80% of the patients. No correlation was found between these reductions and weight loss. Similarly, high-density lipoprotein concentrations decreased until 12 months after surgery. Although concentrations showed a subsequent slight increase, target or lower high-density lipoprotein values were achieved at 24 months postintervention in 85% of the patients.
Bariatric surgery is effective for the treatment of obese diabetic patients, contributing to their metabolic control and reducing their cardiovascular risk.
减肥手术是肥胖糖尿病患者代谢控制的一种重要手段。本研究旨在确定肥胖糖尿病患者在减肥手术后的前4年中体重、碳水化合物及脂质代谢的变化。
对104例2型糖尿病患者(71例女性;平均年龄53.0[0.9]岁;平均体重指数46.8[0.7])进行了一项回顾性研究,这些患者均接受了腹腔镜近端胃旁路手术,糖尿病病程中位数为3年。
术后第1至3个月期间血糖水平和糖化血红蛋白浓度下降。在研究期的剩余时间里数值保持稳定,80%的患者可停用降糖治疗。未观察到因体重指数、糖尿病病程或既往抗糖尿病治疗而产生的显著差异。体重在术后第15至24个月下降,之后略有上升。总胆固醇、甘油三酯和低密度脂蛋白水平显著下降,80%的患者在12个月后达到目标值。这些降低与体重减轻之间未发现相关性。同样,高密度脂蛋白浓度在术后12个月前下降。尽管浓度随后略有上升,但在干预后24个月时,85%的患者达到了目标或更低的高密度脂蛋白值。
减肥手术对肥胖糖尿病患者的治疗有效,有助于他们的代谢控制并降低心血管风险。